2nd International Summit on

Advanced ENT, Head & Neck Surgery

THEME: "Shaping the Future of ENT Care through Innovation and Excellence"

img2 15-16 Mar 2027
img2 London, UK
Anu Jose

Anu Jose

The University Hospital of West Indies, Kingston, Jamaica

Title: Navigating Aggressive Jaw Malignancies: Multidisciplinary Management of Mandibular Chondroblastic Osteosarcoma


Biography

Dr. Anu Jose practices as a Oral and Maxillofacial Surgeon at The University Hospital of the West Indies, Kingston, Jamaica, and as an Oral and Maxillofacial Oncologist at FOSA Surgical Associates.

Dr. Jose's academic journey commenced with her comprehensive post-graduate training in OMFS at PMNM Dental College and Hospital This rigorous residency provided extensive exposure to the full spectrum of oral and maxillofacial pathology, establishing the foundation for her subsequent subspecialization.

Her Fellowship in Oral Oncology from the distinguished SGM Cancer Center has equipped her

with unparalleled expertise in managing complex head and neck malignancies. Her pursuit of advanced fellowship training in oral oncology reflects her dedication to mastering the most complex aspects of head and neck cancer management, positioning her among the elite practitioners in this highly specialized field.

 

Dr. Jose's intellectual contributions to the field are substantiated by her impressive portfolio of

over 32 peer-reviewed publications in prestigious journals indexed within PubMed and Scopus

databases. Her research addresses critical areas of clinical relevance, with particular emphasis on oncological outcomes, reconstructive innovations, and evidence-based surgical protocols.

 

Dr. Jose's commitment to advancing the field through innovation is exemplified by her two recent patent achievements: "A Scale for Evaluation of Asymmetry of Lip Following Lip Reconstruction in Patients with Oral Squamous Cell Carcinoma" (Registration Number L-152732/2024) and “Color Doppler flowmetry to evaluate facial skin margins in patients being operated for oral squamous cell carcinoma” (Registration Number: LD-20260188013)

This groundbreaking development addresses a critical gap in post-operative assessment protocols, providing clinicians with a standardized methodology for evaluating functional and aesthetic outcomes following complex lip reconstruction procedures.

Abstract